STEVE KlRSH: So You Saved (Maybe) 10,000 Lives With the Vaxx But You Killed 150,000!
The truth is coming out.
Like a tidal wave, it is slowly building pressure and soon will come crashing down on shore.
And it can’t be stopped. Not now. Too many people are now awake.
One of those leading the charge is Steve Kirsch, and he’s presenting especially damning information about the vaccine.
He claims it was KNOWN how many deaths the vaccine would cause, and they did it anyway.
Being generous, he explains why you could estimate the vaxx (maybe) saved 10,000 lives.
But then he shows with the VAERS public data that — at a minimum — it killed 150,000.
Good trade off?
Not to me.
Definitely not if you’re one of the 150,000.
Watch it right here :
Here’s more:
Gold from the Pfizer Docs, courtesy of Steve Kirschhttps://t.co/gdPCF79SAc pic.twitter.com/Brd5x76Ose
— LCHF Matt (@LCHF_Matt) March 9, 2022
Zoom in:
And I’ve been saying this for a long time now.
Take what the CDC says, take what the MSM pushes, take what Biden (tries to) read from his teleprompter….and just do the opposite!
Think the 150,000 was bad?
So who is Steve Kirsh?
Here is a bit more according to TechnologyReview:
In the early days of the pandemic, as billions of dollars poured into the hunt for novel treatments and vaccines, veteran Silicon Valley entrepreneur Steve Kirsch did what he’s always done: He went looking for an underdog.
Since making a fortune as the founder of Infoseek, an early search engine that was the Google of its day, Kirsch has spent tens of millions of dollars fighting humanity’s biggest threats. He prefers iconoclastic approaches, whether by directly funding asteroid detection or advocating for nuclear power to combat global warming.
By March 2020, he’d settled on the idea of searching for covid treatments in the pre-existing pharmacopeia. The premise made sense: Most experts were predicting vaccines would take years, while finding helpful drugs with known safety profiles could shortcut the approval process.
With little government funding available for such work, Kirsch founded the Covid-19 Early Treatment Fund (CETF), putting in $1 million of his own money and bringing in donations from Silicon Valley luminaries: the CETF website lists the foundations of Marc Benioff and Elon Musk as donors. Over the last 18 months, the fund has granted at least $4.5 million to researchers testing the covid-fighting powers of drugs that are already FDA-approved for other diseases.
That work has yielded one promising candidate, the antidepressant fluvoxamine; other CETF-funded efforts have been less successful. But that’s not a surprise, according to researchers who conducted them: the vast majority of trials for any drug end in failure.
What has alarmed many of the scientists associated with CETF, though, are Kirsch’s reactions to the work he’s funded—both successes and failures. He’s refused to accept the results of a hydroxychloroquine trial that showed the drug had no value in treating covid, for instance, instead blaming investigators for poor study design and statistical errors.
He’s also publicly railed against what he claims is a campaign against drugs like fluvoxamine and ivermectin. And, according to three members of CETF’s scientific advisory board, he put pressure on them to promote fluvoxamine for clinical use without conclusive data that it worked for covid.
